Clinical trial

Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes

NCT00117780

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record insulin detemir Normalized identity: insulin detemirView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention insulin aspart Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-06-01

PhasePHASE4

Conditions

Diabetesverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 1candidate · MONDO: type 1 diabetes mellitus

Interventions

insulin detemirDRUG · verified · RxNorm: insulin detemir

insulin aspartDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

LilleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00117780 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.